Akara Raises $5.5M for Privacy-Preserving Hospital AI
A room becoming available is useful information only when the next team hears about it. Akara, the Irish hospital technology company, is building sensors and AI around that ordinary handoff, where staff can lose time checking activity that has already happened.
On November 11, 2026, Akara announced $5.5M in funding led by Locke Health, taking disclosed funding to $12.3M. The capital will support hospital adoption, operations and engineering expansion, and further AI-agent development. Its relevance to healthcare AI lies in how the company gets information from physical spaces into the decisions people make around them.
Funding the work between clinical tasks
Akara's latest financing includes VTC Ventures, the EIC Fund, CommonKind and NovaVector Holdings, alongside existing investors ACT, Atlantic Bridge and Enterprise Ireland, plus strategic angels. The announcement leaves the series label and valuation undisclosed. The $12.3M figure includes the new round; it is the cumulative amount, rather than another financing alongside the $5.5M.
Trinity College Dublin's account places the company inside a longer robotics research history. The university identifies a founding team comprising Conor McGinn, Cian Donovan, Niamh Donnelly, Michael Cullinan and Eamon Bourke. McGinn is co-founder and CEO; Donnelly is co-founder and CTO. That combination puts robotics and software experience behind a product sold to the people responsible for keeping clinical spaces working.
The use of proceeds follows the work required after a hospital expresses interest. Akara plans to expand its operations and engineering teams, including in Ireland, while accelerating adoption and developing AI agents for additional healthcare applications. Building that capacity matters because a live hospital installation creates a continuing operating relationship: the product has to remain useful as staff, schedules and room activity change around it.
The company reports deployments in Ireland, the UK and the U.S.; its release specifically identifies U.S. hospitals and ambulatory surgery centers. Those settings provide a commercial base for the expansion. The announcement does not supply a revenue figure or an independently audited, company-wide measure of capacity improvement.
A sensor gives the software somewhere to start
Akara's technology page describes a wall-mounted thermal sensor that interprets activity on the device and sends event information onward. The system is designed to recognize how a room is being used without transmitting detailed visual images of the people inside it. Staff can receive notifications through an app, SMS or email, and inspect utilization and timing information.
This changes the input required from the hospital team. A tool that depends on somebody entering each room's status competes with the work that person is already doing. Passive sensing offers Akara a way to collect the operational record while staff continue caring for patients and preparing spaces, which makes data collection itself part of the product's value.
Akara also offers Cara, a natural-language interface for questions about room activity, and a UV-C disinfection robot connected to its broader technology offering. These products occupy different parts of the operating sequence: sensing establishes what is happening, software makes that information available, and robotics introduces a physical response. Wider automation is a stated development direction, with the funding supporting further applications.
For a hospital buyer, the useful question becomes quite concrete: which recurring coordination task becomes easier once a room can report its own activity? An earlier notification might help a team prepare, while a utilization view might help managers examine how space is being used. The value depends on the workflow being changed and the people who can act on the information, rather than on the presence of another dashboard.
Hospital adoption shaped the product
Niamh Donnelly's October 24 interview with Business Plus gives the sensor strategy a practical history. She described working hospital cleaning shifts as the team learned about the environment for its disinfection robots. She also described U.S. interest in a sensor prototype and characterized the greater emphasis on sensing as a reprioritization.
That account helps explain why Akara's commercial proposition has expanded beyond a machine completing a task. Knowing that a room is ready affects the people and services on either side of the cleaning cycle. Learning from those adjacent decisions can broaden the problem a robotics company is able to address, while keeping the hospital's working routine at the center of product development.
The investor mix brings healthcare operating experience into that expansion. The ADAPT research center's announcement identifies Locke Health's Cerner and Oracle Health experience and VTC Ventures' connection to the Virginia Tech and Carilion ecosystem. Those relationships are relevant to a company navigating healthcare adoption, although the funding announcement promises no particular customer outcome from them.
Akara's own company history connects the present offering to more than a decade of university research. The commercial work now involves explaining that technology through an everyday operational problem. A hospital manager has to understand who receives the alert, what action follows and where the responsibility sits when the room's status changes.
Privacy follows the information into the workflow
The thermal-sensing design addresses a specific concern: capturing activity in clinical spaces without collecting conventional detailed video of patients and staff. That design choice is central to Akara's pitch. It also makes the boundary between sensor data and the wider platform worth understanding before treating privacy as a single product badge.
Akara's privacy policy, updated May 1, 2026, says the platform may process limited protected health information when electronic health record integrations use medical record numbers. The company describes regional infrastructure in Ireland and the U.S. and customer agreements governing such processing. A hospital evaluating the system therefore still has data flows and integration responsibilities to examine, even with on-device thermal interpretation.
This is where the funding's engineering and operations plans meet the buying decision. The company needs people who can help an institution understand the installation, the information it generates and the work that information supports. Akara's current careers page describes a team operating across Ireland and the U.S., consistent with that transatlantic effort.
As the company expands, each installation will place its sensors inside a different pattern of rooms, staff and services. The handoff that started with a room becoming available will reach into the software, the alert and the person preparing the next patient, giving Akara's growing team a very particular place to keep learning.
Healthcare AI funding, last 30 days
DevCuration's funding database tracked 25 Healthcare AI rounds totaling $1.7B in disclosed capital over the past 30 days. Recent deals we covered:
- XpertDox Raises $20M Series A to Scale AI Medical CodingSeries A · $20M · Nov 13
- Mosaic Intelligence Labs Discloses $47M in Seed Financing$47M · Nov 12
- Oura Agrees to Acquire Counsel Health in $625M Cash DealM&A · $625M · Nov 12
- Zus Health Raises $33M Series B for Connected Patient DataSeries B · $33M · Nov 12
- Charta Health Raises $55M Series B for AI Chart ReviewSeries B · $55M · Nov 11
Frequently Asked Questions
How does Akara turn room activity into information hospital teams can use?
Akara uses wall-mounted thermal sensors and on-device AI to detect activity in clinical spaces. Its software supplies event notifications, utilization information and natural-language questions through Cara, helping staff coordinate work around those spaces.
Does thermal sensing mean Akara never processes patient information?
The sensor is designed to interpret activity without transmitting detailed visual images of patients or staff. Akara separately states that its wider platform may process limited protected health information when electronic health record integrations use medical record numbers, so the integration still needs appropriate governance.
What work is the new funding intended to support?
Akara plans to accelerate hospital adoption, expand operations and engineering teams, including in Ireland, and develop AI agents for more healthcare applications. The announcement describes intended investment rather than a guaranteed improvement in hospital capacity.
How do the $5.5M round and $12.3M funding total relate?
The $5.5M announced on November 11, 2026 is the new financing. The disclosed $12.3M total already includes that round; the company did not disclose a series label or valuation.
Why are healthcare investors relevant to Akara’s expansion?
Locke Health led the round, and VTC Ventures and CommonKind are among the healthcare-specialist investors involved. The institutional announcement highlights healthcare operating experience and ecosystem connections that are relevant to adoption, without promising particular sales or customer outcomes.
Where the Money Moved
The intelligence briefing of the innovation economy. Funding, M&A, debt and fund closes, read as market signal rather than deal announcements.
Subscribe to Where the Money Moved
